Trials / Completed
CompletedNCT05699291
Cost of Using FLUOrescence to Green of Indocyanine for the Detection of Breast Cancer.
Analysis of the Cost of Using FLUOrescence in Green of Indocyanine for the Detection of the Sentinel Lymph Node in the Breast Cancer.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 163 (actual)
- Sponsor
- GCS Ramsay Santé pour l'Enseignement et la Recherche · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to analyze the average direct costs of each of these techniques, represented by the costs directly linked to the management of breast cancer, to the surgical intervention and to the techniques evaluated (Indocyanine Green and isotopes) which are: consultations, hospitalizations, resources consumed during the surgical intervention, as well as the time of the patients, transport...
Detailed description
The main objective is to evaluate the overall cost at 1 month of the sentinel lymph node detection technique using Indocyanine Green compared to the technique using isotopes in patients with breast cancer, from the point of view of health insurance and the hospital. The chosen time horizon is up to 1 month post-intervention. The choice of this time horizon corresponds to the usual duration of follow-up for patients who have benefited from one of the sentinel lymph node detection techniques, in order to collect the main post-surgical complications. This is a multicenter, prospective, observational, non-randomized study, aimed at comparing the overall cost of two sentinel lymph node detection techniques (Indocyanine Green and isotope) from a dual perspective (health insurance and hospital).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Sentinel node detection technique | Patients cared for by a surgeon for histologically proven breast cancer and for whom an indication for detection of the sentinel lymph node is posed. |
Timeline
- Start date
- 2023-02-23
- Primary completion
- 2024-05-17
- Completion
- 2024-05-17
- First posted
- 2023-01-26
- Last updated
- 2024-06-05
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05699291. Inclusion in this directory is not an endorsement.